$0.20
+0.01 (+7.57%)
Open$0.20
Previous Close$0.19
Day High$0.21
Day Low$0.19
52W High$4.02
52W Low$0.20
Volume—
Avg Volume1.52M
Market Cap5.94M
P/E Ratio—
EPS$-5.31
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+15,035.3% upside
Current
$0.20
$0.20
Target
$30.77
$30.77
$21.48
$30.77 avg
$35.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.68M | 60.52M | 759.7K |
| Net Income | -1,429,349,563 | -4,168,550,248 | -24,634 |
| Profit Margin | -7,652.8% | -7,270.1% | -3.2% |
| EBITDA | -1,201,046,396 | -3,697,323,642 | -38,889 |
| Free Cash Flow | — | — | -29,815 |
| Rev Growth | -69.1% | -69.1% | +6.1% |
| Debt/Equity | — | — | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |